Eton Pharmaceuticals, Inc.
ETONNASDAQHealthcare● Active
$29.95
+$0.82(+2.81%)
Market Cap$820401122
P/E Ratio—
52W High$35.66
52W Low$13.09
Eton Pharmaceuticals, Inc.（ETON）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ETON · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $79.95M | $39.01M | $31.64M | $21.25M | $21.83M |
| Cost of Revenue | $37.21M | $15.60M | $10.58M | $6.93M | $2.62M |
| Gross Profit | $42.74M | $23.41M | $21.06M | $14.32M | $19.21M |
| Gross Margin %(computed) | 53.46% | 60.01% | 66.56% | 67.38% | 87.99% |
| Operating Expenses | |||||
| R&D Expenses | $7.76M | $3.25M | $3.32M | $4.00M | $6.24M |
| G&A Expenses | $35.82M | $22.75M | $18.93M | $18.58M | $14.47M |
| Total Operating Expenses | $42.67M | $26.01M | $22.25M | $22.58M | $20.70M |
| Operating Income | $0.07M | ($2.60M) | ($1.19M) | ($8.26M) | ($1.50M) |
| Operating Margin %(computed) | 0.09% | -6.66% | -3.77% | -38.87% | -6.85% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $4.78M | $2.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($4.56M) | ($3.81M) | ($0.69M) | ($9.02M) | ($1.96M) |
| Income Tax Expense | $0.04M | $0.01M | $0.25M | $0.00M | $0.00M |
| Net Income | ($4.60M) | ($3.82M) | ($0.94M) | ($9.02M) | ($1.96M) |
| Net Margin %(computed) | -5.75% | -9.80% | -2.96% | -42.45% | -8.95% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.17 | $-0.15 | $-0.04 | $-0.36 | $-0.08 |
| Wtd Avg Shares | 26.91M | 25.89M | 25.64M | 25.15M | 25.21M |
| EBITDA | $4.12M | ($1.45M) | ($0.29M) | ($6.49M) | ($1.03M) |
| EBITDA Margin %(computed) | 5.15% | -3.72% | -0.92% | -30.52% | -4.73% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Eton Pharmaceuticals, Inc.
关于Eton Pharmaceuticals, Inc.（ETON）损益表
Eton Pharmaceuticals, Inc.（ETON）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ETON实现营收$0.08B，毛利润$0.04B（毛利率53.46%），净利润($0.00B)（净利率-5.75%）。
常见问题
ETON · 4 问Eton Pharmaceuticals, Inc.（ETON）2025财年营收为$0.08B，同比up104.9%。
ETON revenueETON salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09